1. Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Veterinary Pharmaceuticals Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Veterinary Vaccines
6.4.2. Veterinary Antibiotics
6.4.3. Veterinary Parasiticides
6.4.4. Other Veterinary Pharmaceuticals
6.5. Market Segmentation By End User
6.5.1. Veterinary Hospitals
6.5.2. Veterinary Clinics
6.5.3. Pharmacies And Drug Stores
6.6. Market Segmentation By Route Of Administration
6.6.1. Oral
6.6.2. Other Route Of Administration
6.7. Market Segmentation By Type Of Animal
6.7.1. Livestock
6.7.2. Companion Animals
6.8. Market Segmentation By Type Of Vaccine
6.8.1. Inactivated Vaccines
6.8.2. Attenuated Vaccines
6.8.3. Recombinant Vaccines
6.8.4. Other Vaccines
7. Major Trends And Strategies
7.1. Stem Cell Therapy To Treat Animals
7.2. Use Of Artificial Intelligence
7.3. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
7.4. Use Of Microchipping Technology
7.5. Development Of Chewable Tablets
7.6. Use Of Telemedicine Platforms To Reduce The Impact Of COVID-19
7.7. Increasing Technological Advancements
7.8. Use Of Next Generation Sequencing (NGS)
7.9. Development Of Vaccines
7.10. Super-Combo Parasiticides
7.11. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)
8.2.1. Market Drivers 2016 – 2021
8.2.2. Increased Disease Prevalence
8.2.3. Market Restraints 2016 – 2021
8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 – 2026
8.3.2. Market Restraints 2021 – 2026
9. Global Market Segmentation
9.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.4. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.5. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Tax Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.4. Asia-Pacific Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia Pacific Veterinary Pharmaceuticals Market: Country Analysis
11.8. China Market
11.9. Summary
11.10. Market Overview
11.10.1. Country Information
11.10.2. Market Information
11.10.3. Background Information
11.10.4. Government Initiatives
11.10.5. Regulations
11.10.6. Regulatory Bodies
11.10.7. Major Associations
11.10.8. Corporate Tax Structure
11.10.9. Taxes Levied
11.10.10. Investments
11.10.11. Major Companies
11.11. China Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.12. China Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.13. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.14. China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.15. India Market
11.16. India Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.17. India Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.18. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.19. India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.20. Japan Market
11.21. Japan Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.22. Japan Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.23. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.24. Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.25. Australia Market
11.26. Australia Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.27. Australia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.28. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.30. Indonesia Market
11.31. Indonesia Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.32. Indonesia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.33. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.34. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.35. South Korea Market
11.36. South Korea Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.37. South Korea Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.38. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.39. South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.4. Western Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
12.8. UK Market
12.9. UK Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.10. UK Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.11. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.12. UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.13. Germany Market
12.14. Germany Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.15. Germany Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.16. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.17. Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.18. France Market
12.19. France Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.20. France Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.21. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.22. France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Tax Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.4. Eastern Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
13.8. Russia Market
13.9. Russia Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.10. Russia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.12. Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.4. North America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.5. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Veterinary Pharmaceuticals Market: Country Analysis
14.8. USA Market
14.9. Summary
14.10. Market Overview
14.10.1. Country Information
14.10.2. Market Information
14.10.3. Background Information
14.10.4. Government Initiatives
14.10.5. Regulations
14.10.6. Regulatory bodies
14.10.7. Major Associations
14.10.8. Taxes Levied
14.10.9. Corporate Tax Structure
14.10.10. Investments
14.10.11. Major Companies
14.11. USA Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.12. USA Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.13. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.14. USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.4. South America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.5. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Veterinary Pharmaceuticals Market: Country Analysis
15.8. Brazil Market
15.9. Brazil Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.10. Brazil Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
16.4. Middle East Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
16.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Veterinary Pharmaceuticals Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
17.4. Africa Veterinary Pharmaceuticals Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
17.5. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Zoetis Inc
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Merck & Co., Inc.
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Boehringer Ingelheim International GmbH
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Elanco Animal Health Incorporated
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Ceva Sante Animale
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers and Acquisitions
19.1. Vimian Group Acquired Heiland GmbH
19.2. Dechra Acquired Med-Pharmex
19.3. Bimeda Acquired Afrivet
19.4. Dechra Pharmaceuticals Acquired Piedmont Animal Health
19.5. Virbac Acquired Assets Of Elanco Animal Health Inc.
19.6. Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.
19.7. Swedencare AB Acquired Animal Pharmaceuticals Inc.
19.8. Elanco Animal Health Acquired Bayer Animal Health
19.9. MSD Animal Health Acquired Worldwide Rights of VECOXAN from Elanco Health
19.10. Boehringer Ingelheim Acquired Global Stem cell Technology
19.11. Merck & Co. Inc. Announced The Acquisition Of Virbac’s Anti-Parasitic Portfolio
19.12. The Carlyle Group Acquired SeQuent Scientific Ltd.
19.13. Friulchem Acquired Pharmabbie
19.14. Manna Pro Acquired Promika, LLC Pet Brands
20. Opportunities And Strategies
20.1. Global Veterinary Pharmaceuticals Market In 2026 – Countries Offering Most New Opportunities
20.2. Global Veterinary Pharmaceuticals Market In 2026 – Segments Offering Most New Opportunities
20.3. Global Veterinary Pharmaceuticals Market In 2026 – Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Veterinary Pharmaceuticals Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. The Business Research Company
22.5. Copyright and Disclaimer
22.6.